News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
542,428 Results
Type
Article (35265)
Company Profile (78)
Press Release (507085)
Multimedia
Podcasts (38)
Webinars (9)
Section
Business (154343)
Career Advice (1029)
Deals (26586)
Drug Delivery (67)
Drug Development (63278)
Employer Resources (88)
FDA (13886)
Job Trends (11485)
News (264129)
Policy (25436)
Tag
Academia (2063)
Accelerated approval (4)
Adcomms (15)
Allergies (78)
Alliances (35850)
ALS (68)
Alzheimer's disease (1027)
Antibody-drug conjugate (ADC) (81)
Approvals (13925)
Artificial intelligence (197)
Autoimmune disease (14)
Automation (8)
Bankruptcy (221)
Best Places to Work (9132)
BIOSECURE Act (11)
Biosimilars (46)
Biotechnology (59)
Bladder cancer (73)
Brain cancer (22)
Breast cancer (237)
Cancer (1851)
Cardiovascular disease (145)
Career advice (899)
Career pathing (17)
CAR-T (113)
Cell therapy (308)
Cervical cancer (17)
Clinical research (52411)
Collaboration (576)
Compensation (281)
Complete response letters (12)
COVID-19 (1845)
CRISPR (26)
C-suite (201)
Cystic fibrosis (58)
Data (1951)
Decentralized trials (2)
Denatured (18)
Depression (35)
Diabetes (216)
Diagnostics (5064)
Digital health (14)
Diversity (5)
Diversity, equity & inclusion (26)
Drug discovery (75)
Drug pricing (71)
Drug shortages (24)
Duchenne muscular dystrophy (72)
Earnings (62902)
Editorial (27)
Employer branding (12)
Employer resources (81)
Events (84847)
Executive appointments (621)
FDA (15069)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (6)
Funding (559)
Gene editing (67)
Generative AI (13)
Gene therapy (207)
GLP-1 (516)
Government (3706)
Grass and pollen (3)
Guidances (120)
Healthcare (15895)
Huntington's disease (11)
IgA nephropathy (22)
Immunology and inflammation (64)
Indications (25)
Infectious disease (1934)
Inflammatory bowel disease (99)
Inflation Reduction Act (6)
Influenza (34)
Intellectual property (65)
Interviews (123)
IPO (12382)
IRA (26)
Job creations (2697)
Job search strategy (821)
Kidney cancer (10)
Labor market (18)
Layoffs (259)
Leadership (10)
Legal (5674)
Liver cancer (64)
Lung cancer (268)
Lymphoma (127)
Machine learning (5)
Management (32)
Manufacturing (177)
MASH (63)
Medical device (13519)
Medtech (13524)
Mergers & acquisitions (14649)
Metabolic disorders (519)
Multiple sclerosis (65)
NASH (13)
Neurodegenerative disease (62)
Neuropsychiatric disorders (13)
Neuroscience (1439)
NextGen: Class of 2025 (5265)
Non-profit (3834)
Now hiring (19)
Obesity (251)
Opinion (115)
Ovarian cancer (65)
Pain (73)
Pancreatic cancer (73)
Parkinson's disease (120)
Partnered (17)
Patents (138)
Patient recruitment (98)
Peanut (39)
People (48144)
Pharmaceutical (21)
Pharmacy benefit managers (17)
Phase I (15628)
Phase II (22849)
Phase III (17906)
Pipeline (1089)
Policy (98)
Postmarket research (2243)
Preclinical (6314)
Press Release (70)
Prostate cancer (94)
Psychedelics (22)
Radiopharmaceuticals (205)
Rare diseases (261)
Real estate (4222)
Recruiting (30)
Regulatory (17795)
Reports (22)
Research institute (1866)
Resumes & cover letters (124)
Rett syndrome (5)
RNA editing (4)
RSV (22)
Schizophrenia (60)
Series A (86)
Series B (63)
Service/supplier (4)
Sickle cell disease (39)
Special edition (6)
Spinal muscular atrophy (117)
Sponsored (17)
Startups (2662)
State (1)
Stomach cancer (10)
Supply chain (46)
Tariffs (21)
The Weekly (20)
Vaccines (439)
Venture capitalists (17)
Weight loss (159)
Women's health (22)
Worklife (7)
Date
Last 7 days (696)
Last 30 days (2314)
Last 365 days (24842)
2025 (8918)
2024 (27425)
2023 (31634)
2022 (41398)
2021 (44819)
2020 (43340)
2019 (37869)
2018 (28726)
2017 (25436)
2016 (24871)
2015 (29645)
2014 (23068)
2013 (19303)
2012 (20719)
2011 (21403)
2010 (20675)
Location
Africa (545)
Alabama (43)
Alaska (6)
Arizona (149)
Arkansas (11)
Asia (31139)
Australia (5010)
California (4600)
Canada (1767)
China (440)
Colorado (207)
Connecticut (220)
Delaware (137)
Europe (65554)
Florida (736)
Georgia (160)
Idaho (46)
Illinois (451)
India (21)
Indiana (269)
Iowa (5)
Japan (153)
Kansas (86)
Kentucky (22)
Louisiana (9)
Maine (66)
Maryland (769)
Massachusetts (3343)
Michigan (217)
Minnesota (353)
Mississippi (2)
Missouri (67)
Montana (27)
Nebraska (23)
Nevada (58)
New Hampshire (62)
New Jersey (1493)
New Mexico (18)
New York (1357)
North Carolina (825)
North Dakota (7)
Northern California (2056)
Ohio (159)
Oklahoma (9)
Oregon (25)
Pennsylvania (1103)
Puerto Rico (9)
Rhode Island (27)
South America (827)
South Carolina (24)
Southern California (1731)
Tennessee (96)
Texas (738)
United States (18189)
Utah (155)
Virginia (118)
Washington D.C. (55)
Washington State (352)
West Virginia (3)
Wisconsin (62)
542,428 Results for "american medical alert corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Regulatory
FDA Action Alert: GSK, Sanofi, Merck and More
On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s oral cancer drug for a pair of rare tumors.
May 5, 2025
·
6 min read
·
Tristan Manalac
FDA
FDA Action Alert: Regeneron, Sanofi and Abeona
Lined up for the FDA in the coming weeks are a cell-based gene therapy for a rare skin disease and two product expansions for Regeneron, one with partner Sanofi.
April 14, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Quipt Home Medical Corp. to Announce Fiscal Second Quarter 2025 Financial Results on May 12, 2025
April 30, 2025
·
1 min read
Regulatory
FDA Action Alert: Amgen, Aldeyra and Argenx
In the coming two weeks, the FDA is expected to announce three big decisions, including one for a dry eye disease therapy.
March 31, 2025
·
3 min read
·
Tristan Manalac
Deals
Bionoid Pharma Extends Letter of Intent to Acquire Global Alerts Corp.
Bionoid Pharma, Inc. is pleased to announce the extension of the effective period of a Letter of Intent, along with its exclusivity provisions, with Global Alerts Corp., as initially disclosed on March 22, 2023.
August 24, 2023
·
2 min read
Press Releases
Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida
March 5, 2025
·
9 min read
Press Releases
Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea
March 5, 2025
·
12 min read
Press Releases
AdaptHealth Corp. Announces First Quarter 2025 Results
May 6, 2025
·
17 min read
Press Releases
BioSig Enters into an LOI to Merge with Streamex Exchange Corp.
May 6, 2025
·
4 min read
Regulatory
FDA Action Alert: GSK, Alnylam, Sanofi and More
On the agenda for the FDA this month are two RNA-based treatments for rare diseases.
March 10, 2025
·
7 min read
·
Tristan Manalac
1 of 54,243
Next
